Although no literature data concern AP-2γ, Li et al. found oncogenic AP-2β to be synchronously localized in both nucleus and cytoplasm in breast cancer patients with high AP-2β expression; no cytoplasmic distribution was observed in patients with low AP-2β [43]. This evidence concerns the gene TFAP2B and breast carcinoma.